News

March 04, 2019
Allergan to Present at The Cowen and Company 39th Annual Health Care Conference

DUBLINMarch 4, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Cowen and Company 39th Annual Health Care Conference in Boston, Massachusetts. The presentation will begin at 3:30 p.m. Eastern Time on Monday, March 11, 2019.

Allergan plc logo

The presentation will be webcast live and can be accessed on Allergan's Investor Relations website at https://www.allergan.com/investors/events-presentations. The webcast can also be accessed through the following URL: http://wsw.com/webcast/cowen52/agn/

An archived version will be available following the live presentation and can be accessed at the same location for 90 days.

About Allergan plc

Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.

Allergan markets a portfolio of leading brands and best-in-class products primarily focused on four key therapeutic areas including medical aesthetics, eye care, central nervous system and gastroenterology.

Allergan is an industry leader in Open Science, a model of research and development, which defines our approach to identifying and developing game-changing ideas and innovation for better patient care. With this approach, Allergan has built one of the broadest development pipelines in the pharmaceutical industry.

Allergan's success is powered by our global colleagues' commitment to being Bold for Life. Together, we build bridges, power ideas, act fast and drive results for our customers and patients around the world by always doing what is right.

With commercial operations in approximately 100 countries, Allergan is committed to working with physicians, healthcare providers and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives every day.

For more information, visit Allergan's website at www.Allergan.com.

CONTACTS:      

Allergan:
Investors:
Manisha Narasimhan, PhD
(862) 261-7162

Christine Chiou
(862) 261-7396

Media:
Amy Rose
(862) 289-3072

Lisa Brown
(862) 261-7320

YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE

Notice

The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?